• Monday
  • July 4, 2022

Intramyocardial injections of erythropoietinanalogue C.E.R.A. in ischemic cardiomyopathy: the ALSTER C.E.R.A. trial

April 25, 2022 Medicine No Comments

Objectives: Erythropoietin (EPO) improved cardiac regeneration in experimental modelsof ischemic heart disease. A pilot trial found subcutaneously administered EPO to improvesurrogate markers of left ventricular (LV) function in ischemic cardiomyopathy. Thisclinical study tests the feasibility and safety of the intramyocardial delivery route of a longacting …..

Evaluating “Helleborus cyclophyllus” extract’s cytotoxic activity against malignant and normal cell lines· preliminary evidence of gastric acid resistance, and a promising therapeutic window

April 22, 2022 Ayurvedic & Alternative Medicine No Comments

Helleborus cyclophyllus is an ancient pharmaceutical plant that exhibits remarkable invitro cytotoxic activity against malignant cell lines. In the present study, we evaluated thecytotoxic activity of Helleborus cyclophyllus dried powdered rhizome’s aqueous extractin both malignant (PC3, TPC1, K1 ) and normal ( Nthy-ori 3.1) cell …..

Narcotic use and pain control after cesarean section

April 5, 2022 Gynecology & Neonatology No Comments

Opioid use and dependence have markedly increased in recent years which has led to anopioid epidemic. Various factors that have contributed to this crisis, one being the overprescription of opioid medication to post-surgery patients. In the United States cesareansection deliveries accounted for 31.8% of all …..